8/16/26
HANGZHOU COCO HEALTHCARE PRODUCTS CO.,LTD. (301009.SZ) Thesis: Recent sales performance has been negatively impacted by rising costs and increased competition, leading to concerns about future profitability.
★ Analysts see FY2027 revenue reaching $1.3B — +7.9% growth in a single year.
What Moves the Stock 1 Changes in consumer spending patterns in China 2 Fluctuations in raw material costs, particularly for packaging and chemicals 3 Regulatory changes affecting product safety and labeling 4 Market share gains or losses against competitors 5 Personal care products - 60% 6 Household cleaning products - 30% 7 Other health-related products - 10% 8 Sustainability in consumer products 7.6 9.2 10.8 12.5 14.1 9.10 301009.SZ Daily 9.10 Mar '26 May '26 Jul '26 Aug '26
My Notes "Management noted, 'We are facing unprecedented challenges in maintaining margins amidst rising input costs and competitive pressures.'" Moat: Coco Healthcare's brand loyalty and distribution network provide a moderate level of competitive advantage. value - due to its low valuation metrics and stable cash flow generation. Low - as a consumer goods company, interest rates have minimal direct impact on operations… Watch on earnings: Consumer Sentiment (UMCSENT), Retail Sales (ex Auto) (RSXFS), Core CPI (CPILFESL). One Sentence Summary: Hangzhou Coco Healthcare Products Co.,Ltd.: the story is balanced — changes in consumer spending patterns in china.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.